Predictive Oncology Net Profit Margin 2010-2023 | POAI
Predictive Oncology net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Predictive Oncology Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $0.00B | $-0.01B | -1300.00% |
| 2023-09-30 | $0.00B | $-0.02B | -1800.00% |
| 2023-06-30 | $0.00B | $-0.02B | inf% |
| 2023-03-31 | $0.00B | $-0.03B | inf% |
| 2022-12-31 | $0.00B | $-0.03B | inf% |
| 2022-09-30 | $0.00B | $-0.03B | inf% |
| 2022-06-30 | $0.00B | $-0.03B | inf% |
| 2022-03-31 | $0.00B | $-0.02B | inf% |
| 2021-12-31 | $0.00B | $-0.02B | inf% |
| 2021-09-30 | $0.00B | $-0.02B | inf% |
| 2021-06-30 | $0.00B | $-0.03B | inf% |
| 2021-03-31 | $0.00B | $-0.03B | inf% |
| 2020-12-31 | $0.00B | $-0.03B | inf% |
| 2020-09-30 | $0.00B | $-0.03B | inf% |
| 2020-06-30 | $0.00B | $-0.03B | -2700.00% |
| 2020-03-31 | $0.00B | $-0.02B | -2200.00% |
| 2019-12-31 | $0.00B | $-0.02B | -2000.00% |
| 2019-09-30 | $0.00B | $-0.01B | -900.00% |
| 2019-06-30 | $0.00B | $-0.01B | inf% |
| 2019-03-31 | $0.00B | $-0.01B | inf% |
| 2018-12-31 | $0.00B | $-0.01B | inf% |
| 2018-09-30 | $0.00B | $-0.01B | inf% |
| 2018-06-30 | $0.00B | $-0.01B | inf% |
| 2018-03-31 | $0.00B | $-0.01B | inf% |
| 2017-12-31 | $0.00B | $-0.01B | inf% |
| 2017-09-30 | $0.00B | $-0.01B | inf% |
| 2017-06-30 | $0.00B | $-0.01B | inf% |
| 2017-03-31 | $0.00B | $-0.01B | inf% |
| 2016-12-31 | $0.00B | $-0.01B | inf% |
| 2016-09-30 | $0.00B | $-0.01B | inf% |
| 2016-06-30 | $0.00B | $-0.01B | inf% |
| 2016-03-31 | $0.00B | $-0.01B | inf% |
| 2015-12-31 | $0.00B | $-0.00B | inf% |
| 2015-09-30 | $0.00B | $-0.00B | inf% |
| 2015-06-30 | $0.00B | $-0.00B | inf% |
| 2015-03-31 | $0.00B | $-0.01B | inf% |
| 2014-12-31 | $0.00B | $-0.01B | inf% |
| 2014-09-30 | $0.00B | $-0.01B | inf% |
| 2014-06-30 | $0.00B | $-0.01B | inf% |
| 2014-03-31 | $0.00B | $-0.01B | inf% |
| 2013-12-31 | $0.00B | $-0.01B | inf% |
| 2013-09-30 | $0.00B | $-0.01B | inf% |
| 2013-06-30 | $0.00B | $-0.01B | inf% |
| 2013-03-31 | $0.00B | $-0.01B | inf% |
| 2012-12-31 | $0.00B | $-0.01B | inf% |
| 2012-09-30 | $0.00B | $-0.01B | inf% |
| 2012-06-30 | $0.00B | $-0.01B | inf% |
| 2012-03-31 | $0.00B | $-0.01B | inf% |
| 2010-03-31 | $0.00B | $-0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.763B | 20.73 |
| Inspire Medical Systems (INSP) | United States | $5.181B | 0.00 |
| Axonics (AXNX) | United States | $3.439B | 0.00 |
| 10x Genomics (TXG) | United States | $3.145B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.107B | 0.00 |
| Azenta (AZTA) | United States | $2.928B | 159.12 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.910B | 0.00 |
| Enovis (ENOV) | United States | $2.800B | 20.75 |
| Hims & Hers Health (HIMS) | United States | $2.768B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 120.20 |
| Schrodinger (SDGR) | United States | $1.673B | 0.00 |
| Omnicell (OMCL) | United States | $1.389B | 48.02 |
| Phreesia (PHR) | United States | $1.238B | 0.00 |
| Standard BioTools (LAB) | United States | $0.699B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.610B | 0.00 |
| Talkspace (TALK) | United States | $0.483B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.428B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.394B | 0.00 |
| Pulmonx (LUNG) | United States | $0.340B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.314B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.231B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.205B | 0.00 |
| Outset Medical (OM) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.152B | 0.00 |
| TruBridge (TBRG) | United States | $0.123B | 5.26 |
| Augmedix (AUGX) | United States | $0.122B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.060B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| CareCloud (CCLD) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |